Automated assessment of Ki-67 proliferation index in neuroendocrine tumors by deep learning

被引:16
作者
Vesterinen, Tiina [1 ,2 ,3 ]
Saila, Jenni [3 ]
Blom, Sami [4 ]
Pennanen, Mirkka [1 ,2 ]
Leijon, Helena [1 ,2 ]
Arola, Johanna [1 ,2 ]
机构
[1] Univ Helsinki, HUS Diagnost Ctr, Dept Pathol, HUSLAB, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[4] Aiforia Technol Oy, Helsinki, Finland
关键词
deep learning; digital pathology; Ki-67 proliferation index; neuroendocrine neoplasm; DIGITAL-IMAGE-ANALYSIS; QUANTIFICATION; CONCORDANCE; GUIDELINES; MANAGEMENT; AGREEMENT;
D O I
10.1111/apm.13190
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Ki-67 proliferation index (PI) is a prognostic factor in neuroendocrine tumors (NETs) and defines tumor grade. Analysis of Ki-67 PI requires calculation of Ki-67-positive and Ki-67-negative tumor cells, which is highly subjective. To overcome this, we developed a deep learning-based Ki-67 PI algorithm (KAI) that objectively calculates Ki-67 PI. Our study material consisted of NETs divided into training (n = 39), testing (n = 124), and validation (n = 60) series. All slides were digitized and processed in the Aiforia(R) Create (Aiforia Technologies, Helsinki, Finland) platform. The ICC between the pathologists and the KAI was 0.89. In 46% of the tumors, the Ki-67 PIs calculated by the pathologists and the KAI were the same. In 12% of the tumors, the Ki-67 PI calculated by the KAI was 1% lower and in 42% of the tumors on average 3% higher. The DL-based Ki-67 PI algorithm yields results similar to human observers. While the algorithm cannot replace the pathologist, it can assist in the laborious Ki-67 PI assessment of NETs. In the future, this approach could be useful in, for example, multi-center clinical trials where objective estimation of Ki-67 PI is crucial.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 35 条
  • [1] Deep learning assisted mitotic counting for breast cancer
    Balkenhol, Maschenka C. A.
    Tellez, David
    Vreuls, Willem
    Clahsen, Pieter C.
    Pinckaers, Hans
    Ciompi, Francesco
    Bult, Peter
    van der Laak, Jeroen A. W. M.
    [J]. LABORATORY INVESTIGATION, 2019, 99 (11) : 1596 - 1606
  • [2] Beasley MB., 2015, CARCINOID TUMOUR WHO
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements
    Boukhar, Sarag A.
    Gosse, Matthew D.
    Bellizzi, Andrew M.
    Rajan, Anand
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (04) : 607 - 619
  • [5] Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
    Dasari, Arvind
    Shen, Chan
    Halperin, Daniel
    Zhao, Bo
    Zhou, Shouhao
    Xu, Ying
    Shih, Tina
    Yao, James C.
    [J]. JAMA ONCOLOGY, 2017, 3 (10) : 1335 - 1342
  • [6] Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors
    Dogukan, Fatih Mert
    Ozguven, Banu Yilmaz
    Dogukan, Rabia
    Kabukcuoglu, Fevziye
    [J]. ENDOCRINE PATHOLOGY, 2019, 30 (01) : 17 - 23
  • [7] Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning
    Govind, Darshana
    Jen, Kuang-Yu
    Matsukuma, Karen
    Gao, Guofeng
    Olson, Kristin A.
    Gui, Dorina
    Wilding, Gregory. E.
    Border, Samuel P.
    Sarder, Pinaki
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors
    Hacking, Sean M.
    Sajjan, Sujata
    Lee, Lili
    Ziemba, Yonah
    Angert, Mallorie
    Yang, Yihe
    Jin, Cao
    Chavarria, Hector
    Kataria, Nidhi
    Jain, Swachi
    Nasim, Mansoor
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [9] The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
    Halfdanarson, Thorvardur R.
    Strosberg, Jonathan R.
    Tang, Laura
    Bellizzi, Andrew M.
    Bergsland, Emily K.
    O'Dorisio, Thomas M.
    Halperin, Daniel M.
    Fishbein, Lauren
    Eads, Jennifer
    Hope, Thomas A.
    Singh, Simron
    Salem, Riad
    Metz, David C.
    Naraev, Boris G.
    Reidy-Lagunes, Diane L.
    Howe, James R.
    Pommier, Rodney F.
    Menda, Yusuf
    Chan, Jennifer A.
    [J]. PANCREAS, 2020, 49 (07) : 863 - 881
  • [10] Ki67 index and mitotic count: Correlation and variables affecting the accuracy of the quantification in endocrine/neuroendocrine tumors
    Huang, Wei
    Nebiolo, Christian
    Esbona, Karla
    Hu, Rong
    Lloyd, Ricardo
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 48